Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Memantine: Updating a rare success story in pro-cognitive therapeutics
Parisa Karimi Tari, Chris G. Parsons, Graham L. Collingridge, et al.
Neuropharmacology (2023) Vol. 244, pp. 109737-109737
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
Prabhash Nath Tripathi, Ankit Lodhi, Sachchida Nand, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 47-74
Open Access | Times Cited: 38
Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease
Allison Carles, Aline Freyssin, Sarra Guehairia, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology
Hugo Fanlo-Ucar, Pol Picón-Pagès, Víctor Herrera-Fernández, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1208-1208
Open Access | Times Cited: 7
Synthesis of adamantane appended supramolecular amphiphilic bullets: structural and spectral insights
Manchikanti M. Chandrasekhar, D.S. Ramakrishna, Anjaneyulu Bendi, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 139021-139021
Closed Access | Times Cited: 5
Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study
Charlotte Havreng-Théry, Bruno Oquendo, Victoria Zolnowski-Kolp, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine
Małgorzata Lewandowska, Agata Różycka, Teresa Grzelak, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1634-1634
Open Access
Mechanisms of NMDA receptor inhibition by vortioxetine – comparison with fluoxetine
Arseniy S. Zhigulin, Oleg I. Barygin
European Journal of Pharmacology (2025), pp. 177460-177460
Closed Access
Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access
The Sound of Memory: Investigating Music Therapy’s Cognitive Benefits in Patients with Dementia—A Network Meta-Analysis of Randomized Controlled Trials
Berne Ting, Chen-Hsin Su, Daniel Tzu-Li Chen, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 497-497
Open Access | Times Cited: 3
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 2
Familial Alzheimer’s disease mutations in amyloid precursor protein impair calcineurin signaling to NMDA receptors
Steven J. Tavalin
Journal of Biological Chemistry (2024) Vol. 301, Iss. 2, pp. 108147-108147
Open Access | Times Cited: 2
Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management
Ciprian Pușcașu, Cornel Chiriță, Simona Negreş, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11111-11111
Open Access | Times Cited: 1
Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease
Allison Carles, Aline Freyssin, Sarra Guehairia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases
F.-Q. Guo, Xiangnan Qin, Jian Mao, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5700-5700
Open Access | Times Cited: 1
Memantine administration enhances glutamatergic and GABAergic pathways in human hippocampus of Alzheimer´s disease patients
Ivo Fabrik, Rudolf Kupčík, Martin Hořák, et al.
Research Square (Research Square) (2024)
Open Access
Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer’s disease
Shan Ping Yu, Emily Choi, Michael Qize Jiang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1981-1988
Open Access
NMDARs in Alzheimer’s Disease: Between Synaptic and Extrasynaptic Membranes
Sergio Escamilla, Javier Sáez‐Valero, Inmaculada Cuchillo‐Ibáñez
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10220-10220
Open Access
Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure–activity relationship
A Gaur, Yash Pal Singh, Rajiv Sharma, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Dizocilpine derivatives with neuroprotective effect lacking the psychomimetic side effects
Jan Konečný, Anna Misiachna, Markéta Chvojková, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Que sait-on de la mémantine comme traitement de la maladie d’Alzheimer en 2024 ?
Bruno Oquendo, Victoria Zolnowski-Kolp, Joël Belmin
NPG. Neurologie, psychiatrie, gériatrie/NPG (2024)
Closed Access
Linking activation of synaptic NMDA receptors‐induced CREB signaling to brief exposure of cortical neurons to oligomeric amyloid‐beta peptide
Ildete L. Ferreira, Daniela Marinho, Valéria de Rosa, et al.
Journal of Neurochemistry (2024)
Closed Access
Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects
Jan Konečný, Anna Misiachna, Markéta Chvojková, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116981-116981
Open Access
Baseline-dependent enhancement of working memory by memantine in male rats: Involvement of NMDA receptor subunits and CaMKII signaling
Shuo‐Fu Chen, Wan‐Ju Cheng, Chih-Chang Chao, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173904-173904
Closed Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
Emma D. Frost, Shuyan Shi, Vishnu Vardhan Byroju, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1163-1163
Open Access
Page 1 - Next Page

Scroll to top